City

Houston (2)

Chattanooga (1)

Fayetteville (1)

Hackensack (1)

Nashville (1)

New York (1)

Omaha (1)

Rochester (1)

Vancouver (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

S*BIO (1)

TG Therapeutics, Inc. (1)

Collaborator

Intervention

sb1518 (1)

tg-1801 (1)

ublituximab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

indolent lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting

CLL
+9 more

TG-1801
Ublituximab

Fayetteville, Arkansas
+4 more

Jan 20, 2023

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed

Hodgkin Lymphoma
+2 more

SB1518

Omaha, Nebraska
+4 more

Apr 19, 2012